Large Rosacea Foam Study Wants US Participants


A large clinical study is looking for rosacea sufferers with the papules and pustules of rosacea.

The study, called Rosetta, is looking for up to 960 participants for 40 locations across the US. The study will require up to 6 visits over 16 – 17 weeks.

Study Publicity

Following is the official promotional text for the Rosetta Study.

Clinical Trial Opportunity

If you are at least 18 years of age and have papulopustular rosacea, that is rosacea with the symptoms of facial redness and bumps and/or pimples, you are invited to learn more about the Rosetta Study.

The Rosetta Study is a clinical research study evaluating an investigational topical treatment (applied directly to the skin), for people with Rosacea.

The study is being conducted under the care of physicians at approximately 40 clinics and research centers across the United States. Insurance is not needed to participate.   To learn more visit or call 877-731-SKIN (7546).

Study Flyer

The organisers of the trial have provided a promotional flyer: Rosetta-Study.pdf


(click above to view the PDF)

What is the Product?

Although the official product is not mentioned on the Rosetta study website or the PDF, if you search at for “study foam” and “rosacea” which is mentioned on the web site, you will find two candidates – Finacea Foam and Topical Minocycline. Only Trial NCT01555463, Finacea Foam lists two study arms indicated in the trial details.

So if you are eligible for this study, you will have a 50/50 chance to get to try Finacea Foam.

The placebo receiving participants will be important to confirm that the active ingredient is actually responsible for any benefits the treatment produce.

Where Are The Locations?

The Rosetta Study website lists the locations here: About the Rosetta Study.

More Information

For more information see the Rosetta Study Website.

Related Articles

About the Author

About the Author: David Pascoe started the Rosacea Support Group in October 1998. .

Follow Rosacea Support

Subscribe via RSS Feed

Leave your comment here


Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.